2005
DOI: 10.1007/s11094-005-0152-6
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and Antiarrhythmic Activity of 2-Diethylamino-2′,6′-Dimethylphenylacetamide Derivatives

Abstract: Data on the syntheses and structures of a series of new derivatives of 2-diethylamino-2¢,6¢-dimethylphenylacetamide are described. The results of an experimental study of the new compounds on various arrhythmia models in animals are presented. Several substances effectively preventing the onset of ventricular ischemia, reperfusive and toxic fibrillation, and ischemic arrhythmia have been selected, which are superior to the reference drug lidocaine with respect to their antiarrhythmic properties.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2008
2008
2018
2018

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 5 publications
0
3
0
Order By: Relevance
“…Two novel pharmacologic substances, developed at The All-Russian Research Centre for Safety of Biologically Active Compounds (Sernov et al 2005) and Ogarev Mordovia State University (Blinov et al 2014), were investigated ( Fig. 1 contains chemical structures of the substances) in the form of fine white water-soluble powder without or with insignificant odour.…”
Section: Substances and Drugsmentioning
confidence: 99%
See 2 more Smart Citations
“…Two novel pharmacologic substances, developed at The All-Russian Research Centre for Safety of Biologically Active Compounds (Sernov et al 2005) and Ogarev Mordovia State University (Blinov et al 2014), were investigated ( Fig. 1 contains chemical structures of the substances) in the form of fine white water-soluble powder without or with insignificant odour.…”
Section: Substances and Drugsmentioning
confidence: 99%
“…In the early 2000s in Russia, a few novel molecules, DPA (Lidocaine) derivatives, were synthetised (Sernov et al 2005). The main reason for developing the substances was the short duration of Lidocaine therapeutic activity, which makes it impossible to administer the drug orally for prophylaxis (Collinsworth et al 1974).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation